Market Cap 540.35M
Revenue (ttm) 332.31M
Net Income (ttm) -51.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15.57%
Debt to Equity Ratio -0.34
Volume 3,374,600
Avg Vol 6,891,648
Day's Range N/A - N/A
Shares Out 201.62M
Stochastic %K 58%
Beta 0.96
Analysts Sell
Price Target $6.08

Company Profile

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovasc...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 734 887 3903
Address:
3891 Ranchero Drive, Suite 150, Ann Arbor, United States
OldManLogan
OldManLogan Oct. 25 at 2:43 PM
$ESPR I think I stole this from one of our other veterans, lol, but I'm here until either eventual multi-multi-billion dollar buyout or Bempedoic Acid becomes a household name... "Somewhere between taking the Jet-Ski out for a spin and having a dip in the Jacuzzi, I used a Kleenex to dry my tears of joy, put dinner in the Crockpot and remembered to take my Bempedoic Acid..." Hmm, that's a bit of a mouthful... we might want to start call Bempo... or Nexlies or someting. Lol.
0 · Reply
Gregg617
Gregg617 Oct. 25 at 2:26 PM
$ESPR Since the company went public in 2017 the company has only ever reported two profitable quarters one in August 2020 and one in May of 2024 both from milestones, we are about to go profitable hopefully for an extended period of time due to sales growth if they achieve that this quarter in two weeks the switch will be flipped forever and PTSD from the stock will melt away
0 · Reply
djohnson591
djohnson591 Oct. 25 at 2:26 PM
$ESPR As I've said in the past. If anyone tried to buy 2m shares of ESPR on the open market for $1.X the price would have rocketed up. Now try to buy 200m shares, It's not going to happen without sending the price into the stratosphere. IMO the key objective to all the offerings is to get cheap shares into the market that can be distributed by "the right people". Here's my opinion on why each offering occurred. Dec2021 offering - Converts were put in place just one year prior to this offering with massive hedges. IMO this offering allowed those shorts and hedges to clean house from $30 to $7 in one year. Mar2023 offering - As we saw, one fund made a decent amount on this offering. 66m+ (nearly all warrants) seemed to be used to pin the stock throughout 2023 and in to 2024. 9m warrants from the Dec2021 offering were amended down from $9 to $1.55 during this offering as well. Continued.....
1 · Reply
BullDonald
BullDonald Oct. 25 at 1:38 PM
$ESPR Statin demonization began… one ☝️ drugs (BA) to rule the world .
0 · Reply
Gregg617
Gregg617 Oct. 25 at 1:34 PM
$ESPR Good for us maybe https://www.eatingwell.com/cholesterol-medication-recall-11836802
0 · Reply
___IFindKarma___
___IFindKarma___ Oct. 25 at 12:30 PM
$ESPR What is interesting in case of Esperion is the the rollout of nextgen ACLY drugs should allow them to be on all places of the graph at same time.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 11:31 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ESPR Current Share Price: $2.71 Contracts: $ESPR January 15, 2027 $3 Calls Scale in: $1.12- $1.38 Scale out: $1.75-$2.25 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 11:12 AM
Enter: $ESPR Calls Strike Price: $3 Expiry Date: NOV 21 2025 Buy in Price: $0.20 - $0.20 Sell Price: $0.37 Profit : +84% (Turn every $1 into $1.84) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
AndreaRR
AndreaRR Oct. 25 at 8:47 AM
$ESPR Interesting graph for interpreting the path of a startup and the launch of a drug, and also the performance of the stock price. In your opinion, is it consistent in the average cases? https://stocktwits.com/rubraquercus/message/633028088
0 · Reply
Choovachok
Choovachok Oct. 25 at 7:49 AM
$ESPR Norm
0 · Reply
Latest News on ESPR
Esperion Announces Pricing of Public Offering of Common Stock

Oct 7, 2025, 9:29 PM EDT - 17 days ago

Esperion Announces Pricing of Public Offering of Common Stock


Esperion Announces Proposed Public Offering of Common Stock

Oct 7, 2025, 4:01 PM EDT - 17 days ago

Esperion Announces Proposed Public Offering of Common Stock


Top 2 Health Care Stocks That May Plunge This Month

Sep 5, 2025, 10:39 AM EDT - 7 weeks ago

Top 2 Health Care Stocks That May Plunge This Month

NUVB


Esperion Appoints Craig Thompson to Board of Directors

Jul 1, 2025, 8:06 AM EDT - 4 months ago

Esperion Appoints Craig Thompson to Board of Directors


Esperion to Participate in The Citizens Life Sciences Conference

Apr 25, 2025, 8:00 AM EDT - 6 months ago

Esperion to Participate in The Citizens Life Sciences Conference


Esperion Appoints Robert E. Hoffman to Board of Directors

Apr 1, 2025, 8:00 AM EDT - 7 months ago

Esperion Appoints Robert E. Hoffman to Board of Directors


Esperion Announces $210 Million Convertible Debt Financing

Dec 13, 2024, 6:00 AM EST - 11 months ago

Esperion Announces $210 Million Convertible Debt Financing


Will The Long Awaited Breakout For Esperion Therapeutics Hold?

Dec 8, 2024, 7:43 AM EST - 11 months ago

Will The Long Awaited Breakout For Esperion Therapeutics Hold?


Esperion Therapeutics: Strategically Positioned To Grow

Aug 16, 2024, 4:09 AM EDT - 1 year ago

Esperion Therapeutics: Strategically Positioned To Grow


Esperion to Participate in Upcoming June Investor Conferences

May 23, 2024, 9:00 AM EDT - 1 year ago

Esperion to Participate in Upcoming June Investor Conferences


OldManLogan
OldManLogan Oct. 25 at 2:43 PM
$ESPR I think I stole this from one of our other veterans, lol, but I'm here until either eventual multi-multi-billion dollar buyout or Bempedoic Acid becomes a household name... "Somewhere between taking the Jet-Ski out for a spin and having a dip in the Jacuzzi, I used a Kleenex to dry my tears of joy, put dinner in the Crockpot and remembered to take my Bempedoic Acid..." Hmm, that's a bit of a mouthful... we might want to start call Bempo... or Nexlies or someting. Lol.
0 · Reply
Gregg617
Gregg617 Oct. 25 at 2:26 PM
$ESPR Since the company went public in 2017 the company has only ever reported two profitable quarters one in August 2020 and one in May of 2024 both from milestones, we are about to go profitable hopefully for an extended period of time due to sales growth if they achieve that this quarter in two weeks the switch will be flipped forever and PTSD from the stock will melt away
0 · Reply
djohnson591
djohnson591 Oct. 25 at 2:26 PM
$ESPR As I've said in the past. If anyone tried to buy 2m shares of ESPR on the open market for $1.X the price would have rocketed up. Now try to buy 200m shares, It's not going to happen without sending the price into the stratosphere. IMO the key objective to all the offerings is to get cheap shares into the market that can be distributed by "the right people". Here's my opinion on why each offering occurred. Dec2021 offering - Converts were put in place just one year prior to this offering with massive hedges. IMO this offering allowed those shorts and hedges to clean house from $30 to $7 in one year. Mar2023 offering - As we saw, one fund made a decent amount on this offering. 66m+ (nearly all warrants) seemed to be used to pin the stock throughout 2023 and in to 2024. 9m warrants from the Dec2021 offering were amended down from $9 to $1.55 during this offering as well. Continued.....
1 · Reply
BullDonald
BullDonald Oct. 25 at 1:38 PM
$ESPR Statin demonization began… one ☝️ drugs (BA) to rule the world .
0 · Reply
Gregg617
Gregg617 Oct. 25 at 1:34 PM
$ESPR Good for us maybe https://www.eatingwell.com/cholesterol-medication-recall-11836802
0 · Reply
___IFindKarma___
___IFindKarma___ Oct. 25 at 12:30 PM
$ESPR What is interesting in case of Esperion is the the rollout of nextgen ACLY drugs should allow them to be on all places of the graph at same time.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 11:31 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $ESPR Current Share Price: $2.71 Contracts: $ESPR January 15, 2027 $3 Calls Scale in: $1.12- $1.38 Scale out: $1.75-$2.25 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 11:12 AM
Enter: $ESPR Calls Strike Price: $3 Expiry Date: NOV 21 2025 Buy in Price: $0.20 - $0.20 Sell Price: $0.37 Profit : +84% (Turn every $1 into $1.84) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
AndreaRR
AndreaRR Oct. 25 at 8:47 AM
$ESPR Interesting graph for interpreting the path of a startup and the launch of a drug, and also the performance of the stock price. In your opinion, is it consistent in the average cases? https://stocktwits.com/rubraquercus/message/633028088
0 · Reply
Choovachok
Choovachok Oct. 25 at 7:49 AM
$ESPR Norm
0 · Reply
wRsYUeX
wRsYUeX Oct. 25 at 5:13 AM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 2:56 AM
Enter: $ESPR NOV 21 2025 $3 CALLS Buy in Price: $0.20 - $0.25 Take Profit: $0.45 Stop Bleeding: $0.22 ROI Potential: 82% https://moneygroup.us/
0 · Reply
augie0030
augie0030 Oct. 25 at 1:51 AM
$ESPR if BP were planning to purchase the company they could have done it for earlier this year for 250M. What is the point of waiting around playing games with a company that could easily do 1B annual revenue with the right sales force? I really dont see what they gain from that and have to assume they arent going to buy us out
2 · Reply
Gregg617
Gregg617 Oct. 25 at 12:50 AM
$ESPR Does anyone else spending their weekends re reading DJ’s posts from the week? If you do I suggest you read them out loud in Christopher Walken voice like I do it’s so hilarious and bad ass😂 https://youtu.be/FZ1mdBYrFBU?si=K700PCwYP9nyZtRG
1 · Reply
Enjoyycall
Enjoyycall Oct. 24 at 11:50 PM
$ESPR We are up over NAMS for the week. And GIA is not a ticker, but must be the latest buzz word sent out, it’s flat for the week btw😽👊🏻🤣 Enjoy the weekend all, leaves are starting to change and autumn is here! 👍🏼
0 · Reply
Albertowest
Albertowest Oct. 24 at 10:39 PM
$ESPR $ESPR in March 2018 market cap was almost 2 billion with 27 million shares outstanding, those 80 bucks would be 8 today I’m sure that at that time bempeodic acid was VERY promising and not yet approved so a lot of expectations surround it, then came approval in 2020 plus COVID and Sheldon lame commercial execution… the rest is history
2 · Reply
HowDidThatGetInThere
HowDidThatGetInThere Oct. 24 at 10:18 PM
$ESPR out of curiosity, I don’t know the full history on this stock, but what were we doing right when the stock was north of $80 back in the day?
1 · Reply
BillyBob1337
BillyBob1337 Oct. 24 at 10:07 PM
0 · Reply
nomalarkey
nomalarkey Oct. 24 at 9:10 PM
0 · Reply
Canyonfundstrader2007
Canyonfundstrader2007 Oct. 24 at 9:02 PM
Im going to destroy any short sellers in $ESPR on next options exp date in November.
1 · Reply
Baruke
Baruke Oct. 24 at 8:04 PM
$ESPR alright Shelly. Since you didnt give the SP a boost with some of your White Wonder, im thinking we need to have an intervention. Ill bring some tissues for your runny nose.
0 · Reply
Skipper777
Skipper777 Oct. 24 at 8:02 PM
$ESPR ready for Monday ✌️ We should all have a beer one day. 😄
1 · Reply